J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 73 (1992), 3169-3175; DOI 10.1099/0022-1317-73-12-3169
© 1992 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clarke, P. A.
Right arrow Articles by Clemens, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clarke, P. A.
Right arrow Articles by Clemens, M. J.
Agricola
Right arrow Articles by Clarke, P. A.
Right arrow Articles by Clemens, M. J.

Expression of genes for the Epstein—Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt's lymphoma cells: effects of interferon treatment

Paul A. Clarke1,{dagger}, Nigel A. Sharp2 and Michael J. Clemens1

1 Division of Biochemistry, Department of Cellular and Molecular Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE
and2 Department of Cell Biology, Wellcome Research Laboratories, Beckenham, Kent, U.K.

The relative levels, rates of synthesis and stabilities of the abundant Epstein—Barr virus (EBV)-encoded small RNAs, EBER-1 and EBER-2, were examined in Daudi Burkitt's lymphoma cells. Although both RNAs are transcribed at approximately equal rates, the steady-state level of EBER-1 is at least 10-fold greater than that of EBER-2. This is shown to be due to a much faster rate of turnover of EBER-2. In the presence of actinomycin D, the half-lives of EBER-1 and EBER-2 are 8 to 9 h and 0.75 h, respectively. Following treatment of the cells with human interferon (IFN) {alpha} the transcription of both RNAs is strongly inhibited. However, the level of EBER-1 increases up to twofold, indicating a further stabilization of this RNA. In IFN-treated cells, EBER-2 accumulates in the form of truncated products. Nuclease protection experiments indicated that this is due to a post-transcriptional modification of the 3' end of the molecule. These data show that the effects of IFN treatment on the expression of these two viral gene products are very complex in cells latently infected with EBV.

{dagger} Present address: Cold Spring Harbor Laboratory, PO Box 100, Cold Spring Harbor, New York 11724, U.S.A.

Received 7 May 1992; accepted 24 August 1992.


This article has been cited by other articles:


Home page
RNAHome page
E. DUMPELMANN, H. MITTENDORF, and B.-J. BENECKE
Efficient transcription of the EBER2 gene depends on the structural integrity of the RNA
RNA, April 1, 2003; 9(4): 432 - 442.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. Rao, H. Jiang, and F. Wang
Cloning of the Rhesus Lymphocryptovirus Viral Capsid Antigen and Epstein-Barr Virus-Encoded Small RNA Homologues and Use in Diagnosis of Acute and Persistent Infections
J. Clin. Microbiol., September 1, 2000; 38(9): 3219 - 3225.
[Abstract] [Full Text]


Home page
J. Virol.Home page
J. Komano, S. Maruo, K. Kurozumi, T. Oda, and K. Takada
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt's Lymphoma Cell Line Akata
J. Virol., December 1, 1999; 73(12): 9827 - 9831.
[Abstract] [Full Text]


Home page
J. Virol.Home page
N. Greifenegger, M. Jager, L. A. Kunz-Schughart, H. Wolf, and F. Schwarzmann
Epstein-Barr Virus Small RNA (EBER) Genes: Differential Regulation during Lytic Viral Replication
J. Virol., November 1, 1998; 72(11): 9323 - 9328.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1992 by the Society for General Microbiology.